Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate advances CBD regulation bill to address public-safety concerns, seeks DEA waiver for medicinal use
Summary
Senators debated and passed second-substitute SB 130 to register and test hemp-derived CBD products for consumer safety and to pursue a DEA waiver to allow medicinal-grade CBD to be prescribed and dispensed through pharmacies.
The Utah Senate on Feb. 21 advanced second-substitute Senate Bill 130, a measure to regulate hemp-grade cannabidiol (CBD) products sold in retail outlets and to create a pathway for medicinal-grade CBD to be prescribed and dispensed through pharmacies if a federal waiver is granted.
Sen. Vickers, who led floor discussion, said the bill directs the Department of Agriculture to register manufacturers and distributors of hemp-grade CBD,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
